Morning stiffness and other patient-reported outcomes of rheumatoid arthritis in clinical practice

Scandinavian Journal of Rheumatology

Volumn 40, Issue SUPPL. 125, 2011, Pages 23-27

  Sokka, Tuulikki ^a  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DISEASE ACTIVITY; DISEASE DURATION; DOCTOR PATIENT RELATION; EMOTION; FATIGUE; FUNCTIONAL STATUS; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HUMAN; MORNING STIFFNESS; PAIN; PATIENT MONITORING; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; SLEEP; STRUCTURED QUESTIONNAIRE; WORK CAPACITY; CIRCADIAN RHYTHM; INTERPERSONAL COMMUNICATION; PATHOPHYSIOLOGY; PATIENT; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SELF EVALUATION; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; CIRCADIAN RHYTHM; COMMUNICATION; DIAGNOSTIC SELF EVALUATION; FATIGUE; HUMANS; PAIN; PATIENTS; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 79955615550     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.566437     Document Type: Article

References (40)

1. Khan NA, Yazici Y, Calvo-Alen J, Dadoniene J, Gossec L, Hansen TM, et al. Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activity. J Rheumatol 2009;36:2435-42.
2. Yazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol 2004;31:1723-6. (Pubitemid 39202511)
3. Leirisalo-Repo M, Paimela L, Peltomaa R, Hieke K, Mottonen T, Sokka T, et al. Functional and radiological outcome in patients with early RA: a longitudinal observational study. Arthritis Rheum 1999;42:S130.
4. Callahan LF, Pincus T, Huston JW, Brooks RH, Nance EP, Kaye JJ. Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res 1997;10:381-94. (Pubitemid 28035144)
5. Wolfe F, Hawley DJ, Cathey MA. Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis. J Rheumatol 1991;18:1290-7.
6. Straub RH, Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 2007;56:399-408.
7. Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 2008;371:205-14.
8. Cobb S, Merchant W, Warren J. An epidemiologic look at the problem of classification in the field of arthritis. J Chron Dis 1955;2:50-4.
9. Ropes MW, Bennett GA, Cobb S, Jacox RF, Jessar RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
11. Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology criteria for remission. J Rheumatol 2003;30:1138-46. (Pubitemid 36666333)
12. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15. (Pubitemid 11022943)
13. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002;46:328-46.
14. Fransen J, Langenegger T, Michel BA, Stucki G. Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology (Oxford) 2000;39:321-7. (Pubitemid 30204219)
15. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84.
16. van Riel PLCM. Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis. Br J Rheumatol 1992;31:793-4.
17. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40. (Pubitemid 23175613)
18. OMERACT, Conference on outcome measures in rheumatoid arthritis clinical trials. Proceedings. Maastricht, the Netherlands, April 29-May 3, 1992. J Rheumatol 1993;20:527-91.
19. van der Heijde DMFM, van't Hof MA, van Riel PLCM, Theunisse LM, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20. (Pubitemid 20360757)
20. van der Heijde DMFM, van't Hof M, van Riel PLCM, van de Putte LBA. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81. (Pubitemid 23102498)
21. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69:1580-8.
22. Felson DT, Smolen J, Wells G, Zhang B, van Tuyl L, Funovits J, et al. American College of Rheumatology/European League against Rheumatism preliminary definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011;63:573-86.
23. Sokka T, Makinen H, Hannonen P, Pincus T. Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology (Oxford) 2007;46:1020-3. (Pubitemid 47064304)
24. Kellgren JH, Lawrence JS. Rheumatoid arthritis in a population sample. Ann Rheum Dis 1956;15:1-11.
25. Yazici Y, Erkan D, Peterson MG, Kagen LJ. Morning stiffness: how common is it and does it correlate with physician and patient global assessment of disease activity? J Rheumatol 2001;28:1468-9. (Pubitemid 32510527)
26. Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the disease activity score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 2003;48:625-30. (Pubitemid 36301996)
27. Pincus T, Chung C, Segurado OG, Amara I, Koch GG. An index of patient self-reported outcomes (PRO Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol 2006; 33:2146-52. (Pubitemid 44749771)
28. Pincus T, Amara I, Koch GG. Continuous indices of Core Data Set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis Rheum 2005;52:1031-6. (Pubitemid 40530108)
29. Yazici Y, Sokka T, Ricciardi DD, Pincus T. Differences in clinical status measures in different ethnic/racial groups with rheumatoid arthritis: implications for interpretation of clinical trial data. J Rheumatol 2007;34:311-15.
30. Pincus T, Yazici Y, Sokka T. Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol 2007;21:601-28. (Pubitemid 47189089)
31. Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis 2009;68:1680-5.
32. Sokka T. How should rheumatoid arthritis disease activity be measured today and in the future in clinical care? Rheum Dis Clin North Am 2010;36:243-57.
33. Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994;21:1227-37. (Pubitemid 24234657)
34. Sokka T, Pincus T. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%- 45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. J Rheumatol 2009;36:1387-90.
35. Sokka T, Haugeberg G, Pincus T. Assessment of quality of rheumatoid arthritis care requires joint count and/or patient questionnaire data not found in a usual medical record: examples from studies of premature mortality, changes in clinical status between 1985 and 2000, and a QUEST-RA global perspective. Clin Exp Rheumatol 2007;25(Suppl 47):S86-97. (Pubitemid 350167893)
36. Pincus T, Swearingen C, Wolfe F. Toward a multidimensional health assessment questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient friendly health assessment questionnaire format. Arthritis Rheum 1999;42:2220-30. (Pubitemid 30263609)
37. Vliet Vlieland TPM, Zwinderman AH, Breedveld FC, Hazes JMW. Measurement of morning stiffness in rheumatoid arthritis clinical trials. J Clin Epidemiol 1997;50:757-63. (Pubitemid 27379784)
38. Hazes JMW, Hayton R, Silman A. A reevaluation of the symptom of morning stiffness. J Rheumatol 1993;20:1138-42. (Pubitemid 23278164)
39. Pincus T, Wolfe F. An infrastructure of patient questionnaires at each rheumatology visit: improving efficiency and documenting care. J Rheumatol 2000;27:2727-30.
40. Pincus T, Yazici Y, Bergman M. Development of a multidimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care. Clin Exp Rheumatol 2005;23:S19-28. (Pubitemid 46661464)